StimCell Energetics Inc.
STME
$0.28
$0.013.70%
| Weiss Ratings | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 6,611.11 | |||
| Price History | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.74% | |||
| 30-Day Total Return | -40.74% | |||
| 60-Day Total Return | -40.41% | |||
| 90-Day Total Return | -34.12% | |||
| Year to Date Total Return | -43.99% | |||
| 1-Year Total Return | -37.78% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -85.02% | |||
| 5-Year Total Return | -93.78% | |||
| 52-Week High % Change | -61.11% | |||
| 52-Week Low % Change | 18,566.67% | |||
| Price | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.72 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Nov 08, 2024 | |||
| 52-Week High Price (Date) | Apr 16, 2024 | |||
| Valuation | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.55M | |||
| Enterprise Value | 5.87M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -89.22% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -5.65 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.28 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -17.87 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 19.82M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 844 238 2692 | |||
| Address | 123 West Nye Lane Carson City, NV 89706 | |||
| Website | stimcell.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -670.96% | |||
| Return on Equity | -- | |||
| Income Statement | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -328.50K | |||
| Net Income (TTM) | -211.40K | |||
| Net Income Avl. to Common (TTM) | -211.40K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -130.58% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 51.39% | |||
| Balance Sheet | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 33.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 38.30K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -982.70K | |||
| Current Ratio (Q) | 0.038 | |||
| Book Value Per Share (Q) | -$0.05 | |||
| Total Assets (Q) | 38.30K | |||
| Total Current Liabilities (Q) | 1.02M | |||
| Total Debt (Q) | 355.80K | |||
| Total Liabilities (Q) | 1.02M | |||
| Total Common Equity (Q) | -982.70K | |||
| Cash Flow | STME - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 121.00K | |||
| Net Change in Cash (TTM) | 11.20K | |||
| Levered Free Cash Flow (TTM) | -1.08M | |||
| Cash from Operations (TTM) | -109.60K | |||
